Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.360
-0.080 (-2.33%)
Jul 31, 2026, 4:08 PM HKT

HKG:1066 Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, HKG:1066 stock has a consensus rating of "Strong Buy" and an average price target of $5.74. The average 1-year stock price forecast is 70.83% higher than the current stock price, while the lowest is $4.01 (+19.35%) and the highest is $8.12 (+141.67%).

Price Target: $5.74 (+70.83%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$4.01$5.74$5.62$8.12
Change+19.35%+70.83%+67.26%+141.67%

Analyst Ratings

The average analyst rating for HKG:1066 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJan '26Feb '26Mar '26Apr '26May '26Jul '26
Strong Buy878888
Buy111111
Hold111222
Sell000000
Strong Sell000000
Total10910111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Citi
No rating
Citi
Buy
Maintains
$6.00
BuyMaintains$6.00+78.57%Jul 21, 2026
Unknown Analyst
UBS
No rating
UBS
Buy
Maintains
$7.00
BuyMaintains$7.00+108.33%May 26, 2026
Goldman Sachs
Goldman Sachs
Hold
Downgrades
$4.00
HoldDowngrades$4.00+19.05%Apr 26, 2026
Unknown Analyst
Zhongtai Securities
No rating
Zhongtai Securities
Buy
Maintains
$4.70
BuyMaintains$4.70+39.88%Apr 10, 2026
Jefferies
Jefferies
Buy
Maintains
$5.50
BuyMaintains$5.50+63.69%Mar 31, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
14.00B
from 13.39B
Increased by 4.56%
Revenue Next Year
15.14B
from 14.00B
Increased by 8.14%
EPS This Year
0.35
from 0.36
Decreased by -1.11%
EPS Next Year
0.47
from 0.35
Increased by 32.55%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
13.21B13.75B13.23B13.09B13.39B14.00B
Revenue Growth
13.65%4.08%-3.77%-1.08%2.31%4.56%
Gross Profit
7.34B7.29B6.61B6.54B6.33B6.45B
Gross Margin
55.54%53.05%49.97%49.94%47.26%46.07%
Operating Income
3.00B3.04B2.18B2.27B1.85B2.04B
Net Income
2.28B2.76B2.00B2.07B1.61B1.60B
EPS
----0.360.35
EPS Growth
-----22.33%-1.11%
Forward PE
12.6317.4811.028.839.058.19
Dividend / Share
0.140.170.170.220.160.15
Dividend Growth
-16.20%1.64%28.44%-27.16%-2.52%
Free Cash Flow
802.50M349.83M968.17M1.64B1.27B2.57B
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High14.2B
Avg14.0B
Low13.7B

Revenue Growth

Revenue Growth202620272028
High
6.1%
Avg
4.6%
Low
2.5%

EPS Forecast

EPS202620272028
High0.38
Avg0.35
Low0.31

EPS Growth

EPS Growth202620272028
High
6.4%
Avg
-1.1%
Low
-13.2%